These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The contribution of exoproducts to virulence of Pseudomonas aeruginosa. Nicas TI; Iglewski BH Can J Microbiol; 1985 Apr; 31(4):387-92. PubMed ID: 2988728 [TBL] [Abstract][Full Text] [Related]
6. Biochemical and genetic aspects of Pseudomonas aeruginosa virulence. Lory S; Tai PC Curr Top Microbiol Immunol; 1985; 118():53-69. PubMed ID: 2414071 [No Abstract] [Full Text] [Related]
7. Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection. Blackwood LL; Stone RM; Iglewski BH; Pennington JE Infect Immun; 1983 Jan; 39(1):198-201. PubMed ID: 6401692 [TBL] [Abstract][Full Text] [Related]
8. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A. Klinger KW; Shuster CW; Klinger J Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609 [TBL] [Abstract][Full Text] [Related]
9. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections. Wretlind B; Pavlovskis OR Scand J Infect Dis Suppl; 1981; 29():13-9. PubMed ID: 6797058 [TBL] [Abstract][Full Text] [Related]
10. Contribution of exotoxin A of Pseudomonas aeruginosa in acute and chronic experimental renal infection. Sharma S; Kaur R; Yadav V; Harjai K; Joshi K Jpn J Infect Dis; 2004 Jun; 57(3):119-20. PubMed ID: 15218223 [TBL] [Abstract][Full Text] [Related]
11. Role of exotoxin A and elastase in the pathogenicity of Pseudomonas aeruginosa strain PAO experimental mouse burn infection. Wretlind B; Björklind A; Pavlovskis OR Microb Pathog; 1987 Jun; 2(6):397-404. PubMed ID: 3148812 [TBL] [Abstract][Full Text] [Related]
12. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay. Klinger JD; Straus DC; Hilton CB; Bass JA J Infect Dis; 1978 Jul; 138(1):49-8. PubMed ID: 98596 [TBL] [Abstract][Full Text] [Related]
13. Antigens of Pseudomonas aeruginosa and their use in immunoprophylaxis and immunotherapy. Stanislavsky ES; Dmitriev BA; Lányi B; Joó I Acta Microbiol Hung; 1985; 32(1):3-37. PubMed ID: 2412389 [No Abstract] [Full Text] [Related]
14. [Significance of Pseudomonas aeruginosa virulence factors for acute and chronic Pseudomonas aeruginosa infections]. Döring G Infection; 1987; 15 Suppl 2():S38-41. PubMed ID: 3112018 [TBL] [Abstract][Full Text] [Related]
15. Combined host and specific anti-Pseudomonas-directed therapy for Pseudomonas aeruginosa infections in burned mice: experimental results and theoretic considerations. Holder IA; Neely AN J Burn Care Rehabil; 1989; 10(2):131-7. PubMed ID: 2496130 [TBL] [Abstract][Full Text] [Related]
16. The contribution of diffusible toxins of Pseudomonas aeruginosa to the pathogenesis of experimental pyelonephritis. Al-Ssum RM; Harris DM J Infect; 1982 Jan; 4(1):49-55. PubMed ID: 6821099 [No Abstract] [Full Text] [Related]
17. Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections. Pollack M; Longfield RN; Karney WW Am J Med; 1983 Jun; 74(6):980-7. PubMed ID: 6407308 [TBL] [Abstract][Full Text] [Related]
18. Incidence and level of exotoxin A in proteolytic cell-free cultures of clinical isolates of Pseudomonas aeruginosa collected from hospitals in Riyadh, Saudi Arabia. al-Ssum RM Microbiologica; 1992 Oct; 15(4):355-9. PubMed ID: 1435349 [TBL] [Abstract][Full Text] [Related]